Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
71
COLL Quote, Financials, Valuation and Earnings
Last price:
$49.56
Seasonality move
:
7.64%
Day range:
$48.50 - $49.59
52-week range:
$23.23 - $49.92
Dividend yield:
0%
P/E ratio:
30.86x
P/S ratio:
2.48x
P/B ratio:
5.70x
Volume:
199K
Avg. volume:
546.7K
1-year change:
70.61%
Market cap:
$1.6B
Revenue:
$631.4M
EPS (TTM):
$1.61
Earnings Data
Next earnings date for COLL
Feb 26
2026
Most recent earnings per share
$0.84
Missed by $1.02
(Nov 6/2025)
Consensus Estimate
$1.86
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
COLL Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $207.1M | -- | -- | $2.15 | -- |
| 11/06/2025 | Q3 | $189.1M | $209.4M | $0.84 | $1.86 | -$1.02 |
| 08/07/2025 | Q2 | $180.9M | $188M | $0.34 | $1.85 | -$1.51 |
| 05/08/2025 | Q1 | $173.1M | $177.8M | $0.07 | $1.45 | -$1.38 |
| 02/27/2025 | Q4 | $179.7M | $181.9M | $0.35 | $1.54 | -$1.19 |
| 11/07/2024 | Q3 | $155.6M | $159.3M | $0.27 | $1.59 | -$1.32 |
| 08/08/2024 | Q2 | $144.6M | $145.3M | $0.52 | $1.49 | -$0.97 |
| 05/09/2024 | Q1 | $146.9M | $144.9M | $0.71 | $1.47 | -$0.76 |
| 02/22/2024 | Q4 | $147.5M | $149.7M | $0.83 | $1.26 | -$0.43 |
| 11/03/2023 | Q3 | -- | -- | $0.53 | $1.24 | -$0.71 |
| 08/03/2023 | Q2 | -- | -- | $0.34 | $1.22 | -$0.88 |
| 05/04/2023 | Q1 | -- | -- | -$0.51 | $1.51 | -$2.02 |
| 02/23/2023 | Q4 | -- | -- | -$0.21 | $1.26 | -$1.47 |
| 11/03/2022 | Q3 | -- | -- | $0.01 | $1.38 | -$1.37 |
| 08/04/2022 | Q2 | -- | -- | -$0.15 | $1.44 | -$1.59 |
| 05/10/2022 | Q1 | -- | -- | -$0.39 | $0.90 | -$1.29 |
| 02/24/2022 | Q4 | -- | -- | -$0.73 | $1.04 | -$1.77 |
| 11/04/2021 | Q3 | -- | -- | $0.22 | $0.96 | -$0.74 |
| 08/05/2021 | Q2 | -- | -- | $1.79 | $0.95 | $0.84 |
| 05/06/2021 | Q1 | -- | -- | $0.41 | $1.00 | -$0.59 |
| 02/25/2021 | Q4 | -- | -- | $0.20 | $0.97 | -$0.77 |
| 11/05/2020 | Q3 | -- | -- | $0.32 | $0.90 | -$0.58 |
| 08/05/2020 | Q2 | -- | -- | $0.23 | $0.86 | -$0.63 |
| 05/07/2020 | Q1 | -- | -- | $0.01 | $0.66 | -$0.65 |
| 02/27/2020 | Q4 | -- | -- | -$0.07 | $0.10 | -$0.17 |
| 11/06/2019 | Q3 | -- | -- | -$0.18 | $0.03 | -$0.21 |
| 08/07/2019 | Q2 | -- | -- | $0.09 | -$0.04 | $0.14 |
| 05/08/2019 | Q1 | -- | -- | -$0.05 | -$0.15 | $0.09 |
| 02/27/2019 | Q4 | -- | -- | -$0.10 | -$0.12 | $0.02 |
| 11/08/2018 | Q3 | -- | -- | -$0.25 | -$0.12 | -$0.13 |
| 08/08/2018 | Q2 | -- | -- | -$0.15 | -$0.33 | $0.18 |
| 05/09/2018 | Q1 | -- | -- | -$0.57 | -$0.65 | $0.08 |
| 03/07/2018 | Q4 | -- | -- | -$0.54 | -$0.55 | $0.01 |
| 11/08/2017 | Q3 | -- | -- | -$0.45 | -$0.73 | $0.28 |
| 08/09/2017 | Q2 | -- | -- | -$0.72 | -$0.81 | $0.09 |
| 05/09/2017 | Q1 | -- | -- | -$0.79 | -$1.00 | $0.21 |
| 03/09/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/10/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/10/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/10/2016 | Q1 | -- | -- | -- | -- | -- |
| 03/15/2016 | Q4 | -- | -- | -- | -- | -- |
Collegium Pharmaceutical, Inc. Earnings Questions
-
How Much did Collegium Pharmaceutical, Inc. Generate in Revenue Last Quarter?
Collegium Pharmaceutical, Inc. reported $209.4M worth of top line sales in its most recent quarter.
-
Did Collegium Pharmaceutical, Inc. Beat Earnings Last Quarter?
Collegium Pharmaceutical, Inc. announced earnings per share of $0.84 which represents a miss of analyst forecast a $1.86 per share.
-
Is Collegium Pharmaceutical, Inc. Profitable?
Collegium Pharmaceutical, Inc. reported $129.2M that represents $3.28 per share over the last quarter.
-
What is the Analyst Consensus for Collegium Pharmaceutical, Inc. EPS Next Year?
Collegium Pharmaceutical, Inc.'s earnings are forecast to grow from $1.86 per share to $6.18 per share next year representing an increase of 302.74%.
-
When is Collegium Pharmaceutical, Inc.'s Earnings Date?
Collegium Pharmaceutical, Inc.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
